Skip to content

Opening book details…

About this Medicine article

8701 ORAL TEMOFRAC – a Phase II Trial – Concurrent 3-times Daily Ultrafractionated Radiation Therapy and Temozolomide for Newly Inoperable Glioblastoma by Beauchesne, P.; Faure, G.; Noel, G.; Schmitt, T.; Martin, L.; Jadaud, M.; Carinin, C. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Beauchesne, P.; Faure, G.; Noel, G.; Schmitt, T.; Martin, L.; Jadaud, M.; Carinin, C.
Publisher
Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0959-8049)
Published
2011
Field
Medicine (Health Sciences)

More by Beauchesne, P.; Faure, G.; Noel, G.; Schmitt, T.; Martin, L.; Jadaud, M.; Carinin, C.

Browse all works by Beauchesne, P.; Faure, G.; Noel, G.; Schmitt, T.; Martin, L.; Jadaud, M.; Carinin, C.